News & Events
Saudi Arabia – Strategic Planning Consultancy Opportunity
MSIF is seeking experienced consultant(s) or a Consultancy Company based in Saudi Arabia to provide mentoring and…
Join our team – Campaign Support Officer
We are looking for a strong communicator to support the World MS Day team at our friendly…
Healthy diet linked to lower disability in people with MS
New study shows eating a diet high in whole grains, fruit, vegetables and legumes may lead to…
Cyprus Multiple Sclerosis Association translates Quality of Life principles into Greek
MSIF’s ‘Seven principles to improve quality of life with MS’, already available in English, Spanish, Arabic, and…
Refining diagnosis for people with MS
Expert panel publishes revised criteria for MS diagnosis
The eyes as possible windows into MS
Two recent scientific publications add further evidence that a simple eye test may offer a fast and…
Singer with MS and young supporters of Japan MS Society perform at school concert
Singer Keiko joined young supporters of the Japan MS Society for a festive, awareness-raising event at an…
Union Roska holds first sports games for people with MS
Czech MS organisation Union Roska marked its 25th anniversary with the Roskiáda Sports Games, a new sports…
People with MS who have additional health conditions are more likely to experience relapses
Canadian study finds people with MS who have additional health conditions face a greater risk of having…
Argentina presents awards to MS researchers
The Association for the Fight Against MS (ALCEM) presents the Miguel Pablo Gallardo award and the Proyecto…
Tawasol – Dec 2017 issue
Latest news from 17 organisations in the Arab region
First treatment for early primary progressive MS approved in Europe
The European Commission has approved the first disease-modifying therapy, ocrelizumab, for early primary progressive MS (PPMS).